XML 142 R126.htm IDEA: XBRL DOCUMENT v3.8.0.1
STOCK-BASED COMPENSATION - Narrative (Details)
12 Months Ended
Dec. 31, 2017
CAD
shares
Dec. 31, 2016
CAD
shares
Dec. 31, 2015
shares
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Liabilities from share-based payment transactions CAD 223,000,000 CAD 189,000,000  
Current liabilities from share-based payment transactions 157,000,000 125,000,000  
Non-current liabilities from share-based payment transactions 66,000,000 64,000,000  
Intrinsic value of liabilities from share-based payment transactions 69,000,000 61,000,000  
Expense from cash-settled share-based payment transactions 107,000,000 69,000,000  
Weighted average exercise price of share options exercised in share-based payment arrangement 42.10 40.45  
Unrecognized stock-based compensation expense, stock options 6,000,000 3,000,000  
Stock-based compensation 61,000,000 61,000,000  
Cash-settled stock options      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Weighted average exercise price of share options exercised in share-based payment arrangement CAD 59.68 51.70  
Stock options      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Share conversion ratio 1    
Awards authorized (in shares) | shares 65,000,000    
Award vesting term 4 years    
Grant exercise price determination term 5 days    
Unrecognized stock-based compensation expense, period of recognition 4 years    
Stock-based compensation CAD 33,000,000 CAD 17,000,000  
Stock options | Minimum      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Award term 7 years    
Stock options | Maximum      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Award term 10 years    
Performance Options      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Number of other equity instruments granted in share-based payment arrangement (in shares) | shares 489,835 420,035  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | shares 1,540,158 2,268,102  
Performance-based RSUs      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Award vesting term 3 years    
Number of other equity instruments granted in share-based payment arrangement (in shares) | shares 133,559 98,889  
Unrecognized stock-based compensation expense, period of recognition 3 years    
Performance-based RSUs | Minimum      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Performance vesting rights 50.00%    
Performance-based RSUs | Maximum      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Performance vesting rights 150.00%    
Restricted share units      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Share conversion ratio 1    
Award vesting term 3 years    
Common Stock, Capital Shares Reserved for Future Issuance | shares 4,000,000    
Number of other equity instruments granted in share-based payment arrangement (in shares) | shares 826,081 763,364  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | shares 1,811,845.000000 2,237,085 2,484,405
Unrecognized stock-based compensation expense, other than options | shares 41,000,000 35,000,000  
Stock-based compensation CAD 51,000,000 CAD 45,000,000  
Performance-based DSUs      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Award vesting term 3 years    
Number of other equity instruments granted in share-based payment arrangement (in shares) | shares 191,875 328,206  
Unrecognized stock-based compensation expense, period of recognition 3 years    
Performance-based DSUs | Minimum      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Performance vesting rights 50.00%    
Performance-based DSUs | Maximum      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Performance vesting rights 150.00%    
Deferred share units      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Award vesting term 3 years    
Number of other equity instruments granted in share-based payment arrangement (in shares) | shares 735,117 972,894  
Number of other equity instruments outstanding in share-based payment arrangement (in shares) | shares 2,327,647.000000 2,396,458 1,770,871
Unrecognized stock-based compensation expense, other than options | shares 22,000,000 30,000,000  
Stock-based compensation CAD 51,000,000 CAD 32,000,000  
Employee Share Accumulation Plan      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Maximum employee contribution percentage 10.00%    
Amount of maximum annual employee contribution CAD 25,000    
Stock-based compensation CAD 43,000,000 41,000,000  
Employee Share Accumulation Plan | Minimum      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Employer percentage, matching contribution 25.00%    
Employee Share Accumulation Plan | Maximum      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Employer percentage, matching contribution 50.00%    
Equity derivatives      
Disclosure of terms and conditions of share-based payment arrangement [line items]      
Stock-based compensation CAD (74,000,000) CAD (33,000,000)